4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-21-002361
Director acquired 6,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Schoeneck James A · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-04 | Exercise or conversion : show line 1 in the form | +6,000 | $9.78 | $58,650 | 15,400 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-01-04 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −6,000 | $9.78 | 2023-04-17 | 6,000 | 0 | D |
Loading xslF345X03/doc4.xml…